GlassScriptPhysician profile
Stephen S Falkowski
NPI 1902879158
$1,053.60
in general payments reported to CMS, 2019-2025
21 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.62 · 2021: $69.91 · 2022: $51.86 · 2023: $143 · 2024: $330 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $375.80 | 2021-2025 | |
| Lilly USA, LLC | $96.44 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $90.98 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $90.78 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Boston Scientific Corporation | $67.04 | 2024 | Wavewriter Alpha Prime 16 |
| Glaxosmithkline, LLC. | $49.94 | 2024-2025 | Shingrix, Bexsero, Trelegy Ellipta |
| Inspire Medical Systems, INC. | $44.34 | 2023-2024 | Inspire |
| Pfizer INC. | $43.70 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $43.42 | 2021-2025 | Airsupra |
| Amgen INC. | $29.99 | 2024 | Repatha, Otezla |
| Alnylam Pharmaceuticals INC. | $23.04 | 2022 | |
| Collegium Pharmaceutical, INC. | $19.44 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $18.97 | 2019 | |
| Ironshore Pharmaceuticals INC. | $15.51 | 2024 | |
| Novo Nordisk INC | $15.39 | 2025 | Ozempic, Rybelsus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $14.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.22 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Falkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.